“…The success of orlistat encouraged the development of PL inhibitors as weight-reducing drugs. In new weight-reducing therapies with more potency or fewer side effects, several natural PL inhibitors, such as platycodin saponins, scabiosaponins, chikusetsusaponins, tea saponins, assamicain A, oolonghomobisflavan A, and oolonghomobisflavan B, have been identified as inhibitors of PL activity in vitro (de la Garza et al, 2011;Han et al, 1999Han et al, ,2005Roh & Jung, 2012;Slanc et al, 2009;Zhao & Kim, 2004;Zheng et al, 2004). However, the compounds are difficult to develop as antiobesity drugs because of limited sources.…”